Jade Biosciences

JBIO · NASDAQ · Pharmaceutical Preparations

Jade Biosciences (JBIO) · oqro.io/stocks/JBIO · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.

How this filing works

Ask Claude or ChatGPT about these filings. Connect OQRO in a minute, then ask things like “which insiders bought this week?”

Want the short version?

Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.

Explain this page What did insiders at JBIO buy and sell in the last 90 days?Which members of Congress and which funds traded JBIO recently?

Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.

Insider trades around earnings

0 open-market purchases and 0 open-market sales by insiders of JBIO between Feb 4, 2026 and today, placed against the company's last 4 earnings releases. The latest on file was filed Nov 13, 2026. The data provider lists the next release for Mar 4, 2027; that date may change.

PurchaseSale30 days before a release30 days after

Trades in the 30 days around each of the last earnings releases
Earnings release	30 days before	On the day	30 days after
Nov 13, 2026	None	None	None
Aug 10, 2026	None	None	None
May 7, 2026	None	None	None
Mar 6, 2026	None	None	None

Companies set trading windows, which usually close shortly before results and reopen after them, and insiders may trade under 10b5-1 plans adopted months earlier. A date alone does not show what a person knew or why they traded. Past release dates are the dates the company filed its 8-K with Item 2.02. An upcoming date, when one is mentioned, comes from the data provider's earnings calendar (Finnhub): it is not a company filing, it is not estimated by OQRO, and it may change. Open-market purchases and sales as reported on Form 4. Largest purchases around earnings, all companies

Insider trades · 1

Insider buying

Tom FrohlichChief Executive Officer

Filed 1y ago

Bought

~$44K6,000 sh @ $7.40

Traded May 16, 2025 · filed 3 days later

The CEO of Jade Biosciences paid $44K out of pocket for Jade Biosciences shares.

More Official record